ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2511

The SHIPE index: A tertile-based approach to predict end-stage kidney disease in ANCA-associated vasculitis

HYUNSUE DO1, Lucy Eunju Lee2, Jang Woo Ha3, Jason Jungsik Song4, Yong-Beom Park5 and Sang-Won Lee6, 1Kangwon national university hospital, Seoul, South Korea, 2Yonsei University, Seoul, Republic of Korea, 3Division of Rheumatology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul, Republic of Korea, 4Yonsei University College of Medicine, Seoul, Republic of Korea, 5Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea, 6Yonsei university college of medicine, Seoul, South Korea

Meeting: ACR Convergence 2025

Keywords: ANCA associated vasculitis, Biomarkers

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2504–2523) Vasculitis – ANCA-Associated Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: This study aimed to develop a simple, robust, and ethnoregion-specific index for predicting progression to end-stage kidney disease (ESKD) in Korean patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Methods: Baseline data from 239 Korean patients with AAV enrolled in a tertiary hospital cohort were analyzed to identify independent predictors of ESKD using univariable and multivariable Cox proportional hazards models. The SHIPE index was constructed by summing the highest tertiles of the identified predictors: Five-Factor Score (FFS ≥2) and serum creatinine (≥1.3 mg/dL), with 1 point assigned to each criterion met. Cumulative ESKD-free survival rates across SHIPE index scores were compared using Kaplan-Meier analysis.

Results: A SHIPE index score of 2 was significantly associated with lower cumulative ESKD-free survival rate compared to scores of 0 or 1 (P< 0.001). By integrating two independent predictors, the SHIPE index provides a simple yet effective tool for risk stratification, demonstrating greater robustness against variability in single predictors such as serum creatinine. This index demonstrated clinical utility, providing a straightforward method for identifying high-risk patients in real-world settings.

Conclusion: The SHIPE index is a novel, robust, and convenient tool for predicting ESKD progression in Korean patients with AAV. This study introduces a practical framework for developing tailored prediction indices that can be adapted for diverse ethnic and regional populations. Its simplicity and practical applicability make it well-suited for routine clinical use. Future prospective studies are needed to validate the SHIPE index in larger, multi-ethnic cohorts and ensure its broader applicability.

Supporting image 1Table 1. Characteristics of 239 AAV patients

Supporting image 2Figure 1. The SHIPE index for AAV patients

Supporting image 3Figure 2. Comparison of three predictors — FFS, serum creatinine, and SHIPE index — for ESKD


Disclosures: H. DO: None; L. Lee: None; J. Ha: Samsung Bioepis, 5; J. Song: None; Y. Park: Samsung Bioepis, 5; S. Lee: None.

To cite this abstract in AMA style:

DO H, Lee L, Ha J, Song J, Park Y, Lee S. The SHIPE index: A tertile-based approach to predict end-stage kidney disease in ANCA-associated vasculitis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/the-shipe-index-a-tertile-based-approach-to-predict-end-stage-kidney-disease-in-anca-associated-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-shipe-index-a-tertile-based-approach-to-predict-end-stage-kidney-disease-in-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology